Iodide

Iodide

SCHEMBL217484

CC(C)(C)c1ccc(S)cc1.CC(C)(C)c1ccc(S)cc1.CC(C)(C)c1ccc(S)cc1.I.I.I

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 3/20 0.39
TSHR P16473 1/20 0.52
LMNA P02545 1/20 0.50
TYR P14679 1/20 0.50
KIF11 P52732 2/20 0.42
ALDH1A1 P00352 4/20 0.41
HPGD P15428 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
HDAC1 Q13547 1/20 0.39
SLC22A2 O15244 1/20 0.39
SLC22A1 O15245 1/20 0.39
SLC22A3 O75751 1/20 0.39
BCHE P06276 3/20 0.39
ALOX15 P16050 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
SRD5A2 P31213 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL67741 0.97 TSHR (0.55) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL6516058 0.94 TSHR (0.52) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL6524730 0.94 TSHR (0.52) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL2742259 0.89 TSHR (0.48) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL16787954 0.89 TSHR (0.48) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL14707718 0.89 KIF11 (0.56) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL5478642 0.89 KIF11 (0.56) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL11158002 0.85 LMNA (0.48) TSHRLMNATYRKIF11ALDH1A1
SCHEMBL23009776 0.83 ADRA2A (0.44) TSHRLMNATYRALDH1A1BCHE
SCHEMBL18843945 0.83 CYP1A2 (0.53) TSHRLMNATYRALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088548-B2 Bottom antireflective coating compositions AZ ELECTRONIC MATERIALS USA CORP. (US) 2012-01-03 US disclosed
EP-2212273-A2 BOTTOM ANTIREFLECTIVE COATING COMPOSITIONS AZ Electronic Materials USA Corp. (US) 2010-08-04 EP disclosed
WO-2009053832-A2 BOTTOM ANTIREFLECTIVE COATING COMPOSITIONS AZ ELECTRONIC MATERIALS USA CORP. (DE) 2009-04-30 WO disclosed
US-20090104559-A1 Bottom Antireflective Coating Compositions MERCK PATENT GMBH (DE) 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090104559-A1 Bottom Antireflective Coating Compositions SDC2, S100A9, MYH9 ACHE 3212/4885TSHR 4603/4885LMNA 686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.